Condition
Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia clinical trials that are recruiting, in China. 1 was first registered in the last 30 days. By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 1Country
All recruiting trials (2)
-
CD19 and CD22 in vivo CAR-T therapy for relapsed/refractory B-ALL
This study tests a one-of-a-kind in vivo CAR-T treatment that targets CD19 first and then CD22 in adults with relapsed or refractory B-ALL to see if it is safe and possibly effective.
-
Adaptive dual-target CAR-T therapy for relapsed or refractory blood cancers
This trial will test whether matching a patient's cancer markers to one of several dual-target CAR-T therapies can work and be safe for adults whose blood cancer has come back or not responded.
Related topics
Quick answers
How many Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.